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December 2005456Lett r to the Editor
Re: Oxytocin induction of labour: a comparison 
of two protocols
Different protocols of oxytocin infusion have been introduced
in the literature for labour induction.1–3 High-dose short-interval
infusion protocols (in which starting doses are increased
significantly at short intervals) accelerate labour but may
also be associated with increased potential risks of maternal
and fetal complications such as uterine hyperstimulation and
fetal distress. Extensive comparative studies on low and
high-dose protocols are in the literature, none of which have
implemented a long-interval for the high-dose protocol.2,3
Inspired by the fact that oxytocin reaches a steady plasma
level after about 40 min,4 we developed a new protocol of a
high-dose long-interval type and compared its benefits and
complications with those of a traditional protocol in our hospital.
We randomly allocated 110 consecutive post-term preg-
nant women with a Bishop’s score = 4 and no contraindica-
tions for oxytocin induction of labour into two groups, which
are similar in mean age, parity and gestational age. Group A
(50 cases; maternal age 21.48 ± 3.2 years; parity 0.48 ± 0.1;
gestational age 40.9 ± 0.6 weeks) underwent the traditional
protocol (2.5 mU/min for start and increasing steps of 2.5
mU/min by 15-min intervals up to a maximum dose of
40 mU/min), while group B (60 cases; maternal age 24.06 ±
4.4 years; parity 0.18 ± 5.4; 40.4 ± 1.3 weeks) received
the new protocol (5 mU/min for start and increasing steps
of 5 mU/min by 45 min intervals up to a maximum dose of
40 mU/min). Efficacy and complications of the protocols
were compared. P value < 0.05 was considered statistically
significant.
All women had given their written consent to participate in
the study. The performance of the study was consistent with the
ethical guidelines of the Iran University of Medical Sciences.
The results are shown in Table 1. By using the new protocol
and application of 45 min intervals, which is the time required
by oxytocin to reach a steady plasma level and state, we
accelerated the labour more than the traditional protocol.
Moreover, the new protocol did not increase the risk of
fetal and maternal complications.
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Table 1 Efficacy and complications of the high-dose short-interval infusion (traditional) protocol and high-dose long-interval (new)
protocol
 
Group A (n = 50) Group B (n = 60) P value
Caesarean section 13 (26%) 11 (20.7%) N.S.
Fetal distress 4 (30.8%) 3 (27.2%) N.S.
Uterine hyperstimulation 6 (12%) 6 (10%) N.S.
Mean time to active phase (SD) 519 (214) min 308 (152) min < 0.001
Mean duration of active phase (SD) 255 (216) min 167 (82) min < 0.01
Mean total time to delivery (SD) 781 (337) min 463 (192) min < 0.001
Group A received oxytocin via the traditional protocol; group B received oxytocin via the new protocol.
N.S., non-significant; SD, standard deviation.
